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Abstract: Methionine restriction (MetR) in animal models extends maximum longevity and seems to
promote renoprotection by attenuating kidney injury. MetR has also been proven to affect several
metabolic pathways including lipid metabolism. However, there is a lack of studies about the
effect of MetR at old age on the kidney metabolome. In view of this, a mass spectrometry-based
high-throughput metabolomic and lipidomic profiling was undertaken of renal cortex samples of
three groups of male rats—An 8-month-old Adult group, a 26-month-old Aged group, and a MetR
group that also comprised of 26-month-old rats but were subjected to an 80% MetR diet for 7 weeks.
Additionally, markers of mitochondrial stress and protein oxidative damage were analyzed by mass
spectrometry. Our results showed minor changes during aging in the renal cortex metabolome, with
less than 59 differential metabolites between the Adult and Aged groups, which represents about
4% of changes in the kidney metabolome. Among the compounds identified are glycerolipids and
lipid species derived from arachidonic acid metabolism. MetR at old age preferentially induces lipid
changes affecting glycerophospholipids, docosanoids, and eicosanoids. No significant differences
were observed between the experimental groups in the markers of mitochondrial stress and tissue
protein damage. More than rejuvenation, MetR seems to induce a metabolic reprogramming.
Keywords: aging; dietary restriction; mass spectrometry; lipidomics; protein damage; renal cortex
1. Introduction
The physiological aging process involves a loss-of-function of many organs, and the kidney,
which has one of the highest rates of susceptibility to age-dependent tissue damage, is no exception.
In fact, the most common cause of death in male rats is renal failure [1]. In terms of morphological
alterations, the average weight of kidneys progressively decreases with aging, affecting mainly the
renal cortex. The total nephron size and number also decline with aging, and there is a global
increase in glomerulosclerosis, tubular atrophy, and interstitial fibrosis [2]. It has been suggested that
these changes are associated with an age-related increase in lipid accumulation of triacylglycerides
(TAG) and cholesterol content, likely due to changes in the renal expression of transcriptional factor
sterol regulatory element binding protein-1 and -2 (SREBP-1 and SREBP-2) [3]. Interestingly, lipid
accumulation potentially leads to lipid peroxidation and, with advancing age, there is an increase in
renal free radical production along with a decrease in the expression of antioxidant enzymes [4–6].
In this line, levels of F2-isoprostanes are found to be increased in the kidney of old rats [7].
In terms of kidney function, the glomerular filtration rate diminishes with advancing age, as does
renal tubular function. Consequently, the ability of the kidney to both maximally concentrate and dilute
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urine diminishes and the handling of sodium and potassium is also affected [1,8]. Lipid metabolism
has been found to be closely related to the age-related decline in renal function through the role
of arachidonic acid (AA) and its metabolites [9]. Importantly, this finding is supported by the
accumulation of lipid species rich in AA that are found in the lipidomic profile of the kidney [10].
An increase in long-chain ceramides and lysophosphatidylcholine (LPC) species, and a decrease in
phosphatidylcholine (PC) species, all potentially related to the development of renal fibrosis, has been
reported in the aged rodent kidney [11]. A decrease in AA and its metabolites, epoxyeicosatrienoic
acid (EET) and dihydroxyeicosatrienoic acid (HETE), generates an imbalance between vasodilatory
and vasoconstrictive events affecting renal function in aging kidneys [12–14].
Successful aging relies upon a nutritionally complete diet and adequate exercise to counteract
some of the physiologic changes related to age. In fact, dietary restrictions extend both median and
maximum lifespans in several animal species, reduce oxidative stress and resulting molecular damage,
and remodel lipid metabolism into a healthier lipid profile [15]. In this context, previous studies
have demonstrated that dietary methionine restriction (MetR), without changes in energy intake, can
increase maximum lifespan in different experimental models [15–17]. It has also been suggested that
MetR may have a renoprotective effect in aged rodents—Possibly through the action of hydrogen
sulfide in the trans-sulfuration pathway [18]. The application of MetR induces lower mitochondrial
free radical production, and decreases mitochondrial DNA damage and the levels of specific markers
of mitochondrial protein damage of the rat heart and liver, as well as brain and kidney [19–23]. It has
also been reported that MetR is able to reduce the incidence of age-associated degenerative diseases
and improve glucose metabolism by decreasing insulin, insulin-like growth factor 1 (IGF-1), and
glucose levels in blood [24]. Furthermore, MetR induces weight loss along with a reduction of fat
deposition, especially in visceral and ectopic depots [25–27]. Finally, MetR reduces plasma and hepatic
TAGs and cholesterol levels, while lowering and increasing leptin and adiponectin plasma levels
respectively [27–32]. Supporting these biochemical adaptations to MetR, several studies in adult and
young rodents have shown that this anti-aging nutritional intervention induces significant changes in
lipid-related gene and protein expression in a tissue-specific manner, leading to different fatty acid
profiles in adipose tissue, liver, skeletal, and cardiac muscle and the brain [23,28,29,31–35].
All the studies published to date, which have reported MetR modification of different metabolic
pathways, were performed using young immature rodents. It is currently unknown if MetR can also
modify the metabolic profile in aged animals, or whether it can reverse the putative effects of aging.
In particular, it is important to know if a short-term intervention of MetR at old age is beneficial in
animals that have been feeding ad libitum during all their previous lifespan. With that aim, three
groups were established in the study design—Adult (8 months old, control diet), Aged (26 months
old, control diet), and MetR (26 months old, 80% MetR diet). Since MetR has a profound effect
on metabolism, liquid chromatography-mass spectrometry (LC-MS)-based untargeted metabolomic
and lipidomic analyses of renal cortex samples of the three groups were performed. Markers of
mitochondrial stress and tissue protein oxidative damage were also detected and measured by gas
chromatography-mass spectrometry (GC-MS).
2. Results
2.1. Effects of Aging and MetR on Markers of Mitochondrial Stress and Tissue Protein Damage
No significant differences were observed between the Adult and Aged groups, nor between
the Aged and MetR groups, in the marker of mitochondrial stress 2-S-(2-succino)cysteine [2-SC],
and different specific markers of protein oxidation (the protein carbonyls glutamic [GSA] and
aminoadipic [AASA] semialdehydes), glycoxidation (carboxyethyl-lysine [CEL]), lipoxidation
(malondialdehyde-lysine [MDAL]), and mixed glyco- and lipoxidation (carboxymethyl-cysteine
[CMC] and carboxymethyl-lysine [CML]) (Table 1).
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Table 1. Protein damage markers detected and measured by GC-MS in renal cortex.
Compound Adult Aged MetR
2-SC 69.55 ± 7.41 68.82 ± 7.80 72.58 ± 3.01
GSA 5232.67 ± 458.74 5216.56 ± 178.61 5729.25 ± 376.60
AASA 284.64 ± 37.76 276.84 ± 21.80 291.35 ± 21.36
CEL 384.75 ± 42.28 322.70 ± 38.12 329.99 ± 22.78
MDAL 228.53 ± 25.27 203.44 ± 25.44 204.02 ± 43.33
CMC 103.78 ± 15.42 99.27 ± 9.04 103.43 ± 7.04
CML 1595.83 ± 75.82 1410.95 ± 123.92 1494.69 ± 110.89
Values are mean ± SEM of n = 10 specimens per group. Units: µmol/mmol Lys.
2.2. Effect of Aging on the Renal Cortex Metabolome
An untargeted lipidomic and metabolomic approach to define and compare the renal cortex
metabolome of the Adult and Aged groups was designed, and the data obtained were subjected to
an unsupervised multivariate statistical analysis. After filtering those molecules present in at least
50% of the samples of the same group, we obtained 528 species from lipidomics and 839 species from
metabolomics approaches. The principal component analysis (PCA) performed using these molecules
revealed no clear differences between the Adult and Aged experimental groups. Illustrative images
of the multivariate statistics are shown in Figure 1. The first component of the PCA showed only
slight differences between the two groups, with both principal components explaining 17.6% of the
variability across the samples for the lipidomic analysis. In contrast, when hierarchical clustering
analysis was applied, we obtained a better classification of the samples according to the animal age.
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Figure 1. Lipidomic profile of the renal cortex samples of the Adult and Aged experimental groups. (a)
The PCA shows no clear differences between the two experimental groups. (b) Heat map representation
of the 528 compounds found in renal cortex. (c) Heat map representation of the hierarchical clustering
of the 25 lipid species with lower p-values by a non-parametric t-test. Each line represents an accurate
mass ordered by retention time, colored by its abundance intensity, normalized to internal standard,
and baselined to median of all samples. The scale from -3 (blue) to 3 (red) represents this normalized
abundance in arbitrary units. For all of them, data was acquired in the untargeted lipidomic profiling
analysis based on LC-MS with ESI (+).
Moreover, when a comparison was made of the 25 lipid species with the highest statistically
significant differences between the Adult and Aged groups, using a hierarchical clustering analysis
(represente in the heat map of Figure 1), differences were ob erved in the lipid profiles of the two
group . The non-parametric t-test for qual variances that was performed found that 28 compounds
detected from lipidomics and 31 rom metabolomics methodology w re statistic lly significantly
iff rent between the groups. Twelve out of these were identified (Tabl 2). All the un-identified
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compounds obtained by untargeted lipidomics and metabolomics are represented in Table S1. Among
the identified molecules we found almost all the glycerolipid (GL) species and one phosphatidylcholine
(PC) ether lipid up-regulated with advancing age. Furthermore, ADP-ribose and NADH were
significantly decreased in aged animals. Interestingly, a few oxylipins (some of which derive from AA)
that down-regulated in the Aged group were also identified.
Table 2. Details of the identified lipid and metabolite species in rat renal cortex which displayed
statistically significant differences between the Adult and Aged groups.
Compound Adduct m/z RT Log FC p Aged vs Adult
PC(P-34:2) a M+H+ 742.5863 7.64 7.83 0.0253 up
MAG(18:0) a* M+Na+ 381.2909 4.47 13.00 0.00159 up
DAG(32:2) a* M+H+-H2O 529.4520 8.41 7.02 0.0389 up
TAG(50:2) a M+NH4+ 848.7654 9.55 9.02 0.0134 up
TAG(56:8) a M+H+ 903.7554 9.78 -8.74 0.0372 down
TAG(56:5) a M+NH4+ 926.8102 10.01 9.15 0.0242 up
Palmitaldehyde b M+NH4+ 258.2738 9.11 7.20 0.00955 up
EET methyl ester b M+H+-H2O 317.2477 11.83 -6.73 0.0473 down
AA methyl ester b M+NH4+ 336.2908 11.80 -6.85 0.0275 down
Dihomo-PGI2 b M+H+-H2O 363.2525 11.47 -9.34 0.00401 down
ADP-ribose b M+H+-H2O 542.0597 0.58 -9.47 0.0423 down
NADH b M+Na+ 688.1027 5.90 -8.42 0.0418 down
a Compounds detected by the lipidomic approach; b Compounds detected by the metabolomic approach. Results
were obtained by a non-parametric t-test of the data acquired using an untargeted lipidomic and metabolomic
profiling method based on LC-MS with ESI (+). Identities were confirmed by exact mass, retention time and isotopic
distribution. * Compounds identified by MS/MS.
2.3. Effect of MetR on the Renal Cortex Metabolome
The evaluation of the effect of the MetR diet at old age on the renal cortex of rats was also based
on the untargeted metabolomic and lipidomic analyses that were performed. The unsupervised PCA
and the hierarchical clustering analysis showed no clear differences between the three experimental
groups (Adult, Aged, and MetR) for either the lipidomic and metabolomics approaches. Illustrative
images of the multivariate statistics are shown in Figure 2. In line with this, hierarchical clustering
analysis also showed no differences between the groups. However, when a comparison was made of
the 25 compounds with the highest statistically significant differences between the three experimental
groups, using a hierarchical clustering analysis (represented in the heat map of Figure 2), clear
differences were observed.
In order to identify those entities responsible for a specific lipid/metabolic profile in the kidney,
a one-way ANOVA was performed with a post hoc Tukey’s test to compare the three experimental
groups. Out of the 583 lipid species that were detected and filtered in the untargeted lipidomic
analysis, 46 were found to be statistically significantly different between the groups, and 15 of
these were identified (Table 3). Among the 925 metabolites that were detected and filtered in the
untargeted metabolomic analysis, 71 were found to be statistically significantly different between the
groups, and 15 of these were also identified (Table 4). All the non-identified compounds obtained
by untargeted lipidomic and metabolomic analysis are shown in Table S2. Most of the identified
lipid species are glycerophospholipids (GPs), although there are also some sphingolipids (SPs) and
GLs. Of the SP compounds, only two species were identified, a sphingomyelin (SM) and a derivative
of a hexosylceramide (HexCer). In the MetR group, levels of SM and HexCer were upregulated
and downregulated, respectively, with respect to both the Aged and the Adult groups. In addition,
different types of GLs were identified—monoacylglycerides (MAG), diacylglycerides (DAG), and
TAG species. All of them presented polyunsaturated fatty acid (PUFA) chains and were upregulated
in the MetR group with respect to both the Aged and the Adult group. However, regulation in the
MetR group with respect to the Aged control group was different for each lipid, and no pattern was
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detected. Finally, 50% of the PC species that were identified were upregulated in the MetR group
with respect to both the Aged and the Adult group, and the other 50% downregulated. Finally, the
identified lysoglycerophospholipids (LGPs) appeared to be regulated in a class-dependent way (being
the LPE increased and LPI decreased in MetR group, respectively), whereas the identified ether lipids,
phosphatidic acid PA (P-30:1) and phosphatidylserine PS(P-29:0), were upregulated due to the effect of
the MetR diet.
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Figure 2. Lipidomic profiles of the renal cortex samples from animals of the three different experimental
groups. (a) The PCA reveals no clear differences between the groups in the lipidomic profile. (b) Heat
map representation of the 528 compounds found in renal cortex. (c) Heat map representation of the
hierarchical clustering analysis that was performed of the 25 lipid species with lower p-values obtained
by a one-way ANOVA with a post hoc Tukey’s test. Each line represents an accurate mass ordered by
retention time, colored by its abundance intensity, normalized to internal standard, and baselined to
the median of all the samples. The scale from -4 or -2 (blue) to 4 or 2 (red) represents this normalized
abundance in arbitrary units. For all of them, data was acquired in the untargeted lipidomic profiling
analysis based on LC-MS with ESI (+).
Table 3. Details of the identified renal lipid species with statistically significant differences between the
Adult control, Aged control, and MetR groups.
Compound m/z RT p value
LogFC
MetR vs
Aged
MetR vs
Aged
LogFC
MetR vs
Adult
MetR vs
Adult
LysoPE(18:3) * 493.303 0.83 0.0197 10.67 up 5.68 up
LysoPI(15:0) 559.2942 2.97 0.0234 -9.06 down -0.03 down
PA(P-30:1) 585.4237 6.41 0.00000662 14.26 up 12.35 up
PC(20:0) 604.3236 2.13 0.0128 10.73 up 7.02 up
PC(38:6) * 823.5946 5.58 0.00246 8.39 up 0.07 up
PC(42:2) 870.688 7.40 0.0478 -7.80 down -7.05 down
PC(P-38:2) 820.6198 8.70 0.00248 -7.57 down -0.07 down
PG(32:1) 721.5002 7.72 0.0397 0.05 up -0.12 down
PS(P-29:0) 642.453 5.67 0.03 -5.80 down 1.62 up
GlcAβ-Cer(d36:1) 742.5863 7.64 0.002 -10.15 down -1.76 down
SM(d30:0) * 666.5661 8.41 0.02 9.08 up 7.20 up
MAG(20:3) 381.2906 4.48 0.00482 -6.16 down 8.82 up
DAG(32:2) * 529.4533 8.41 0.0173 0.61 up 7.37 up
TAG(40:2) 848.7654 9.56 0.00188 -10.11 down 1.85 up
TAG(61:6) 941.8264 9.94 0.0235 11.11 up 1.74 up
The results were obtained by a one-way ANOVA with a post hoc Tukey’s test of the data acquired using an
untargeted lipidomic profiling method based on LC-MS with ESI (+). The identities were confirmed by xac mass,
retention time, and isotopic distribution. * Compounds identified by MS/MS.
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Table 4. Details of the identified renal metabolite species with statistically significant differences
between the Adult control, Aged control, and MetR groups.
Compound m/z RT p value
LogFC
MetR vs
Aged
MetR vs
Aged
LogFC
MetR vs
Adult
MetR vs
Adult
Methylcytidine 258.0986 0.48 0.0224 -2.27 down 0.69 up
ADP-ribose 542.0597 0.58 0.0036 -0.02 down -2.36 down
Inosine 269.0814 0.67 0.0291 0.01 up -0.12 down
Glutathione disulfide 613.1499 0.46 0.0169 -2.46 down -0.51 down
Angiotensin (1-7) 937.4213 11.50 0.0375 2.29 up 2.58 up
epoxyHDHA 399.2466 10.04 0.0183 2.62 up 0.48 up
10,11-DiHDPE 363.2511 11.47 0.0236 2.35 up 0.05 up
20-carboxy-LTB4 367.2129 7.33 0.0143 -0.11 down 0.00 down
6-keto PGE1 369.2334 6.89 0.0192 -2.37 down -0.51 down
5β-Cholestane-3α,7α-diol 427.3541 13.89 0.0242 -0.07 down 1.98 up
Glycocholic Acid 466.3105 8.93 0.000176 2.89 up 2.85 up
Dodecenoyl-CoA 912.2679 13.69 0.0435 -1.18 down 1.03 up
Formyl-CoA 778.0916 10.56 0.0215 0.55 up -1.75 down
Palmitaldehyde 258.2745 9.11 0.00461 0.01 up 2.69 up
Propionylcarnitine 235.1639 9.19 0.0278 0.00 up 2.36 up
The results were obtained by a one-way ANOVA with a post hoc Tukey’s test of the data acquired using an
untargeted metabolomic profiling method based on LC-MS with ESI (+). The identities were confirmed by exact
mass, retention time, and isotopic distribution.
Different regulation effects were found in the species that were detected and identified with
the metabolomic approach. 10,11-DiHDPE and 20-carboxy-LTB4 were up- and down-regulated,
respectively in the MetR group with respect to both the Adult and Aged groups. With respect to purine
metabolism, inosine was up-regulated and ADP-ribose was down-regulated in the MetR group with
respect to the Aged group. 5-methylcytidine was down-regulated in the MetR group with respect to
the Aged group. The renal cortex fatty acyls that were conjugated with coenzyme A or acylcarnitine
species were also altered in the MetR group, mostly upregulated with respect to both the Adult and
Aged control groups. Bile alcohol and a bile acid were also identified, the latter compound was
upregulated in the MetR group with respect to both the Adult and Aged control groups.
Finally, glutathione disulfide (GSSG) and a prostaglandin were found to be downregulated in the
MetR group with respect to both the Adult and Aged control groups.
3. Discussion
The physiological aging process requires adaptation for the maintenance of metabolic homeostasis
at every biological level (molecular, cellular, organic, and systemic), having to support any imbalance
or shift in the metabolism that can self-intensify, and ultimately clinically manifest itself [36]. The up-
and down-regulation of metabolic pathways provide a specific metabolome for each type of tissue,
and so age-related changes can vary from one tissue to another [10].
In recent years, different studies have performed untargeted metabolomic analyses of plasma and
serum to elucidate the metabolic changes produced with advancing age in both humans and rodents,
demonstrating alterations in lipid homeostasis and one carbon metabolism [37–44]. With respect to
lipid homeostasis, studies performed on 23- and 26-month-old C57BL/6 mice revealed the existence of
a metabolomic signature associated with aging that involves changes in acylcarnitines and a decrease
in plasma levels of LPC, SM, and cholesterol derivatives [37,41], while cholesterol plasma levels were
significantly increased by the aging process in 26-month-old male Wistar rats [45]. Further metabolomic
studies on 117 wild-type mice of different genetic backgrounds ranging from 8–129 weeks of age,
reported a decrease in LPC and SM species and defined phosphatidylethanolamine PE (16:0/18.2) and
PE (16:0/22:6) as biomarkers that increased with the aging process, while ether PE (P-) plasma levels
decreased [40]. Metabolomic studies on human plasma confirmed that SP and GP species, including
LGP and ether lipid species, could be critical candidate metabolites in the aging process [38,39,42–44].
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In addition, these studies point to the importance of acylcarnitine and the β-oxidation process due to
an age-related plasma level increment [38,42].
The untargeted metabolomic and lipidomic analyses of the renal cortex in the present study
demonstrate specific changes associated with the aging process in the metabolome and lipidome of the
analyzed tissue, with lipid metabolism being especially significant. Differences in structural lipids
(GPs), bioactive lipids (oxylipins), and lipid species involved in energy metabolism (acylglycerols)
were found. Initially, the unsupervised multivariate statistical analysis, applied to the results of
the untargeted metabolomic and lipidomic analyses, revealed no differences between the groups,
suggesting that the renal cortex variability with respect to the whole metabolome cannot be explained
by the aging process. However, when a set of differential metabolites was selected, aging was found to
be a key factor that separated the groups, suggesting that this physiological process affects particular
metabolic pathways or even specific reaction steps.
Specifically, in the analyzed renal metabolome, approximately 4% of the polar and non-polar
metabolites were statistically significantly different between the experimental groups. The aging process
in renal tissue did not affect any GP species, except for an increase in PC (P-) species. This age-associated
regulation of ether lipids is in agreement with previous metabolomic studies performed on mice and
human plasma [39,40]. The physiological role of plasmalogens is essentially linked to their function
as membrane components, although other specific functions (as second messenger and antioxidant
components) have been ascribed to them [46,47]. Further studies need to be performed to elucidate the
potential meaning of these changes.
Other structural lipid species such as SP and cholesterol remained unaltered in the renal cortex
during the aging process. The role of SP and cholesterol in biological membranes is the formation
of lateral lipid clusters, denominated lipid rafts, in which particular molecules are concentrated and
participate in membrane-mediated signaling events. The high affinity of SM and cholesterol locates
them together in these microdomains, where the SM concentration seems to control the cholesterol
distribution, and on the surface of the lipoproteins [48]. Furthermore, HexCer helps to stabilize the
membranes, and their complex products, gangliosides, modulate the charge density at the membrane
surface [49,50]. An absence of changes in the composition of structural lipids in the renal cortex means
that their physical properties and function in membranes are maintained during the aging process.
Some AA-derived oxylipins were decreased in the Aged group compared to the Adult group.
Little has been reported in the literature about the physiological roles of oxylipins and the effect of aging
on their metabolism in mammalian tissues. A recent study provided the first comprehensive profile of
oxylipins in the kidney, liver, and serum of adult healthy rats, demonstrating that oxylipin profiles
can be highly divergent across mammalian tissues [51]. The results of the present study showed a
decrease with age in renal AA and its metabolites, which is in agreement with previous published
studies [12–14]. Thus, the age-related decline in renal function could be due to a decrease in AA and its
metabolites that can generate an imbalance between vasodilatory and vasoconstrictive events affecting
the renal function in aging kidneys.
As for lipid involvement in energy metabolism, aging affected the levels of some acylglycerol
species. The renal cortex of the Aged group showed an increase in MAG (18:0) and DAG with PUFA
chains. However, the identified TAG species were found to be both decreased and increased with
aging, depending on the individual lipid species. The increase in acylglycerols with PUFA chains
agrees with previous studies in rodents, where an association of higher levels of MAG, DAG, and TAG
seems to be due to an increase in lipid synthesis, maybe through sterol regulatory element-binding
proteins (SREBP) [3].
A MetR diet has been shown to not only improve biomarkers of metabolic health and increase
longevity in rodents, but also to produce a highly integrated series of physiological and biochemical
responses, including remodeling lipid metabolism into a healthier lipid profile [52]. Several studies
have focused on the effects of MetR on lipid metabolism, showing differences across tissues with
coordinated remodeling of lipid metabolism in liver, skeletal muscle, and adipose tissue—increasing
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lipogenic expression in adipose tissue while decreasing it in liver and skeletal muscle, thus favoring fatty
acid oxidation [23,29,31–35,52–56]. This effect on total fatty acid composition also affects chain length
and the degree of unsaturation of fatty acids from GP, TAG, and cholesterol esters (CE) both circulating
or from the liver, kidney, heart, brain, and skeletal muscle under dietary restriction, suggesting a
metabolic reprogramming that involves an up-regulation of β-oxidation and lower level products of
oxidative damage [7,29,57–63].
Our study used 8- and 26-month-old rats to evaluate the effect of a 7-week diet with methionine
restriction (MetR) on the metabolome and lipidome of aged animals. The number of significantly
altered metabolites and lipid species in the renal cortex of rats subjected to MetR corresponds to
approximately 7.75% of their metabolome. The effect of MetR led to specific remodeling of their
metabolomic and lipidomic profiles. Globally, the differences between the aged animals with and
without MetR strongly indicate that the metabolomic pattern is altered by this dietary intervention.
The differences found in the metabolomic and lipidomic profiles of the 8-month-old adult rats compared
to those of the aged rats subjected to MetR suggest that, while it may not result in a reversal of the
aging-associated metabolic state, this dietary restriction does result in a remodeling/reprogramming of
these profiles.
4. Materials and Methods
Animals and diets. Thirty male Wistar rats of 430–670 g body weight were individually caged and
maintained in a 12:12 (light:dark) cycle at 22 ± 2 ◦C and 50 ± 10% relative humidity. Ten 8-month-old
rats were fed with a control diet (Adult control group), ten 26 months-old rats were also fed with
a control diet (Aged control group), and the final ten, also 26 months old, were fed with an 80%
L-methionine restricted diet (MetR group). The animals were fed ad libitum with a semi-purified diet
prepared by MP Biochemicals (Irvine, CA, USA). The composition of the control diet (in g/100 g of diet)
was—L-arginine 1.12, L-lysine 1.44, L-histidine 0.33, L-leucine 1.11, L-isoleucine 0.82, L-valine 0.82,
L-threonine 0.82, L-tryptophan 0.18, L-methionine 0.86, L-glutamic acid 2.70, L-phenylalanine 1.16,
L-glycine 2.33, dextrine 5.0, corn starch 31.82, sucrose 31.79, cellulose 5.0, choline bitartrate 0.20, MP
vitamin diet fortification mixture 1.0, mineral mix (AIN) 3.50, and corn oil 8.0. The composition of the
methionine restriction diet was similar to that of the control diet except that L-methionine was present
at 0.17% instead of the 0.86% of the control diet. The 80% reduction in L-methionine in the restriction
diet was compensated with increases in the other dietary components in proportion to their presence
in the diet. The two control groups received the same amount of food everyday as the MetR group had
eaten on average the previous week (pair feeding). After 7 weeks of dietary treatment, the animals
were sacrificed by decapitation. The renal cortex samples were immediately processed or frozen at
−80 ◦C for subsequent assays. All procedures followed the protocols approved by the Catalonian
Institutional Committee of Care and Use of Animals (Spain) and the experiments were approved by
the Ethics Committee of the University of Lleida (EAEC 18-01/12).
Markers of mitochondrial stress and tissue protein damage measured by GC-MS. The marker of
mitochondrial stress 2-S-(2-succino)cysteine [2-SC], and different specific markers of protein oxidation
(the protein carbonyls glutamic [GSA] and aminoadipic [AASA] semialdehydes), glycoxidation
(carboxyethyl-lysine [CEL]), lipoxidation (malondialdehyde-lysine [MDAL]), and mixed glyco- and
lipoxidation (carboxymethyl-cysteine [CMC] and carboxymethyl-lysine [CML]) were determined by
gas chromatography-mass spectrometry (GC-MS) in renal cortex samples, as previously described [64].
Markers were determined as trifluoroacetic acid methyl ester (TFAME) derivatives using an HP6890
Series II gas chromatograph (Agilent Technologies, Barcelona, Spain) with an MSD5973A Series and a
7683 Series automatic injector, an Rtx-5MS Restek column (30 mL * 0.25 mm ID * 0.25 µm particle size),
and the described temperature program [64]. Quantification was performed by internal and external
standardization using standard curves constructed from mixtures of deuterated and non-deuterated
standards. Analyses were carried out by selected ion-monitoring GC/MS (SIM-GC/MS). The ions
used were—lysine and [2H8] lysine, m/z 180 and 187, respectively; 5-hydroxy-2-aminovaleric acid
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and [2H5] 5-hydroxy-2-aminovaleric acid (stable derivatives of GSA), m/z 280 and 285, respectively;
6-hydroxy-2-aminocaproic acid and [2H4] 6-hydroxy-2-aminocaproic acid (stable derivatives of AASA),
m/z 294 and 298, respectively; CEL and [2H4] CEL, m/z 379 and 383, respectively; MDAL and [2H8]
MDAL, m/z 474 and 482, respectively; CML and [2H2] CML, m/z 392 and 394, respectively; CMC and
[13C3-15N] CMC, m/z 271 and 273, respectively; and 2-SC and [2H2] SC, m/z 284 and 286, respectively.
The amounts of product were expressed as µmoles of GSA, AASA, CEL, MDAL, CML, CMC, or SC per
mole of lysine. A one-way ANOVA with post hoc Tukey’s test was performed with RStudio statistical
software (RStudio, Inc., Boston, MA, USA).
Tissue homogenization. For untargeted lipidomic analysis, 20 volumes of cold homogenization
buffer (180 mM of potassium chloride (KCl), 5 mM of 3-(N-morpholino)propanesulfonic acid (MOPS),
2 mM of ethylenediamine tetra-acetic acid (EDTA), 1 mM of diethylenetriamine penta-acetic acid
(DTPA), and 1 µM of 2,6-Di-tert-butyl-4-methylphenol (BHT) adjusted to pH 7.4) were added to 50 mg
of tissue. For the untargeted metabolomic analysis, 10 volumes of cold phosphate-buffered saline
solution (pH 7.47) were added to 50 mg of tissue. All samples were homogenized at 4 ◦C with an
Ultra-Turrax (IKA, Staufen, Germany) homogenizer.
Untargeted lipidomic analysis. An untargeted lipidomic analysis was performed using an Agilent
1290 ultra-performance liquid chromatograph (UPLC) coupled to an ESI-QTOF MS/MS 620 model
(Agilent Technologies, Barcelona, Spain) as previously described [35]. For lipid extraction, 10 µL
of the homogenized tissue was mixed with 5 µL of Milli-Q water and 20 µL of ice-cold methanol.
The samples were vigorously shaken by vortexing for 2 min, and then 250 µL of methyl tert-butyl ether
(MTBE), containing internal lipid standards, were added. The samples were immersed in a water bath
(ATU Ultrasonidos, Valencia, Spain) with an ultrasound frequency and power of 40 kHz and 100 W,
respectively, at 10 ◦C for 30 min. Then, 25 µL of Milli-Q water were added to the mixture, and the
organic phase was separated by centrifugation (1400* g) at 10 ◦C for 10 min [65]. The lipid extracts,
contained in the upper phase, were collected and subjected to mass spectrometry. A pool of all lipid
extracts was prepared and used as quality controls. The internal lipid standards used were isotopically
labeled lipids (Table S3). Stock solutions were prepared by dissolving lipid standards in MTBE at
a concentration of 1 mg/mL, and working solutions were diluted to 2.5 µg/mL in MTBE. The lipid
extracts were analyzed following a previously published method [66]. The sample compartment of the
UPLC was refrigerated at 4 ◦C and, for each sample, 10 µL of lipid extract was injected into a Waters
Acquity HSS T3 column (150 mm L, 2.1 mm ID, 1.8 µm particle size) (Waters, Milford, MA, USA)
heated to 55 ◦C. The flow rate was 400 µL/min, with solvent A consisting of 10 mM ammonium acetate
in acetonitrile-water (40:60, v/v) and solvent B of 10 mM ammonium acetate in acetonitrile-isopropanol
(10:90, v/v). The gradient of solvent B went from 40% at the start to 100% at the end after 10 min,
followed by a two minute hold. Finally, the system was switched back to 60% B and was equilibrated
for 3 min.
Untargeted metabolomic analysis. The tissue samples (40 mg) were homogenized in cold
methanol (20 v/w) containing 1 µg/mL of phenylalanine C13 as the internal standard and 1 µM
butylhydroxytoluene as the antioxidant, obtaining a final concentration of 50 mg tissue/mL. Then,
samples were incubated at 20 ◦C for 1 h and centrifuged at 12,000*g for 3 min. The supernatants were
analyzed by liquid chromatography using an Agilent 1290 system coupled to an ESI-Q-TOF MS/MS
6520 model (Agilent Technologies, Barcelona, Spain). In all cases, 2 µL of the extracted sample were
injected into a Zorbax SB-Aq reverse-phase column (50 mm * 2.1 mm ID, 1.8 µm particle size) (Agilent
Technologies, Barcelona, Spain) equipped with a Zorbax-SB-C8 rapid resolution cartridge precolumn
(2.1 mm * 30 mm ID, 3.5 µm particle size) (Agilent Technologies, Barcelona, Spain) with a column
temperature of 60 ◦C. The flow rate was 0.6 mL min−1. Solvent A was composed of water containing
0.2% acetic acid, and solvent B of methanol 0.2% acetic acid. The gradient of solvent B went from 2% at
the start to 98% at the end after 13 min, followed by a 6 min hold at 98%. Post-time was established in
5 min, as previously described [67].
Metabolites 2019, 9, 280 10 of 14
For both untargeted approaches, metabolomics and lipidomics, duplicate runs of the samples
were performed to collect positive and negative electrospray ionized (ESI) lipid species in a TOF mode,
operated in full-scan mode at 100 to 3000 m/z in an extended dynamic range (2 GHz), using N2 as the
nebulizer gas (5 L/min, 350 ◦C). The capillary voltage was set at 3500 V with a scan rate of 1 scan/s.
Continuous infusion using a double spray with masses 121.050873, 922.009798 (positive ion mode) and
119.036320, 966.000725 (negative ion mode) was used for in-run calibration of the mass spectrometer.
Data Analyses and Statistics. Data obtained from the untargeted lipidomic and metabolomic
analysis were acquired using MassHunter Data Analysis software (Agilent Technologies, Barcelona,
Spain). The molecular feature extractor (MFE) algorithm of the MassHunter Qualitative Analysis
software (Agilent Technologies, Barcelona, Spain) was used to obtain the molecular features of
the samples, representing different, co-migrating ionic species of a given molecular entity (i.e., ion
adducts) [68]. This algorithm used the accuracy of the mass measurements to group related ions
(basing on charge-state envelope, isotopic distribution and/or the presence of different adducts and
dimers/trimers) assigning multiple species (ions) to a single compound referred to as a feature. Finally,
the MassHunter Mass Profiler Professional software (Agilent Technologies, Barcelona, Spain) was
used to perform untargeted analysis of the extracted features. Only common features (found in at
least 50% of the samples of the same condition) were taken into account to correct for individual
bias. Multivariate statistical analyses (hierarchical clustering and PCA) were performed using both
MassHunter Mass Profiler Professional and MetaboAnalyst software [69,70]. The masses there were
found to have significant differences by ANOVA (p < 0.05 with Benjamini-Hochberg multiple testing
correction) were searched against the Human Metabolome Database [71] and the LIPID MAPS database
(Lipidomics Gateway, http://www.lipidmaps.org/, May 2014) (exact mass ppm < 20), and the MS/MS
spectra were checked using the LipidBlast software [72] and MassBank Database (massbank.jp/Search).
For a better identification, the retention time of the metabolites and lipid species were confirmed using
authentic standards.
Supplementary Materials: The following are available online at http://www.mdpi.com/2218-1989/9/11/280/s1.
Table S1: Details of the unidentified lipid and metabolite species in rat renal cortex which displayed statistically
significant differences between the Adult and Aged groups. Results were obtained by a non-parametric t-test of
the data obtained using an untargeted lipidomic and metabolomic profiling method based on LC-MS with ESI (+).
Table S2: Details of the unidentified renal lipid species with statistically significant differences between the Adult
control, Aged control, and MetR groups. Results were obtained by a one-way ANOVA with a post hoc Tukey’s
test of the data obtained using an untargeted lipidomic profiling method based on LC-MS with ESI (+). Table
S3: Class representative and extraction internal standards added to the samples in untargeted metabolomic and
lipidomics analysis.
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